Previous Close | 7.70 |
Open | 7.68 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 7.61 - 7.96 |
52 Week Range | 4.00 - 9.86 |
Volume | |
Avg. Volume | 372,437 |
Market Cap | 231.716M |
Beta (5Y Monthly) | 0.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Neurocrine (NBIX) delivered earnings and revenue surprises of -9.89% and 4.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?